The percutaneous mechanical circulatory support (pMCS) devices market is witnessing significant expansion due to the rising prevalence of cardiovascular diseases, technological advancements, and increasing adoption of minimally invasive procedures. These devices play a critical role in stabilizing patients suffering from cardiogenic shock and heart failure by temporarily supporting cardiac function. The demand for pMCS devices has surged globally, especially in emergency care settings and high-risk cardiac interventions.
The percutaneous mechanical circulatory support devices market was valued at US$ 1,474.28 million in 2019 and is projected to reach US$ 3,964.75 million by 2027; it is expected to grow at a CAGR of 13.5% during 2020–2027. In terms of Percutaneous Mechanical Circulatory Support Devices Market growth analysis and Trend, the industry is being shaped by innovations in device miniaturization, improved patient outcomes, and expanding clinical applications. Additionally, the growing geriatric population and increasing incidence of chronic cardiac conditions are fueling demand across developed and emerging economies.
Get Sample PDF @ https://www.theinsightpartners.com/sample/TIPRE00003194
Market Dynamics Driving Growth
The primary driver of the pMCS devices market is the increasing burden of cardiovascular diseases worldwide. Conditions such as heart failure and cardiogenic shock require immediate intervention, and pMCS devices offer a minimally invasive solution compared to traditional surgical methods. According to industry insights, cardiovascular diseases remain one of the leading causes of mortality globally, pushing healthcare providers to adopt advanced support systems.
Technological advancements are another key factor propelling market growth. Manufacturers are focusing on developing compact, efficient, and easy-to-implant devices, improving patient safety and reducing complications. Innovations such as next-generation ventricular assist devices and improved extracorporeal membrane oxygenation (ECMO) systems are expanding the scope of treatment.
Furthermore, the rise in high-risk percutaneous coronary interventions (PCI) has increased the need for temporary circulatory support devices. Hospitals and cardiac centers are increasingly incorporating these devices into treatment protocols, further boosting market adoption.
Market Segmentation Insights
The percutaneous mechanical circulatory support devices market is segmented based on product type, end user, and geography. Key product categories include intra-aortic balloon pumps (IABP), extracorporeal membrane oxygenation (ECMO), and short-term ventricular assist devices. Among these, intra-aortic balloon pumps held a significant market share historically, while ventricular assist devices are expected to witness robust growth due to their advanced capabilities.
By end user, hospitals dominate the market due to the availability of advanced infrastructure and skilled healthcare professionals. Ambulatory surgical centers and specialty clinics are also emerging as important segments due to the increasing preference for minimally invasive procedures.
Emerging Trends in the Market
One of the most prominent trends in the market is the shift toward minimally invasive and catheter-based technologies. These approaches reduce recovery time, lower the risk of complications, and improve patient outcomes. Additionally, the integration of digital health technologies such as remote monitoring and telehealth is enhancing post-procedure care and patient management.
Another notable trend is the growing focus on research and development. Companies are investing heavily in clinical trials to expand the indications of pMCS devices and improve their long-term efficacy. The development of smaller, portable devices is also opening new opportunities for use in a wider patient population.
Regional Analysis
Geographically, North America holds the largest share of the percutaneous mechanical circulatory support devices market, driven by advanced healthcare infrastructure, high healthcare expenditure, and early adoption of innovative technologies. Europe follows closely, supported by favorable reimbursement policies and increasing awareness about advanced cardiac care.
The Asia-Pacific region is expected to witness the fastest growth during the forecast period. Factors such as a rising patient population, improving healthcare infrastructure, and increasing investments in healthcare are contributing to market expansion in countries like China and India.
Competitive Landscape
The market is highly competitive, with several global and regional players focusing on innovation and strategic collaborations. Key players are investing in product development, mergers, and acquisitions to strengthen their market presence.
Top Players in the Percutaneous Mechanical Circulatory Support Devices Market:
- Abbott
- Medtronic
- Getinge AB
- Teleflex Incorporated
- LivaNova PLC
- Abiomed
- Eurosets
- Berlin Heart
- Jarvik Heart, Inc.
- CardioBridge GmbH
Future Outlook
The future of the percutaneous mechanical circulatory support devices market looks promising, with continued advancements in technology and increasing adoption of minimally invasive procedures. The market is expected to benefit from ongoing research, rising healthcare investments, and the growing need for effective cardiac care solutions.
Related Report:
1) Vascular Screening Market Growth, Trends & Demand by 2034
2) Aortic Repair Devices Market Share, Size & Demand by 2034
3) Stromal Vascular Fraction Market Demand, Size & Forecast by 2034
About Us -
The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.
Contact Us:
Ankit Mathur | The Insight Partners
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876
Also Available in : Korean German Japanese French Chinese Italian Spanish
